The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Nature

Volumn 450, Issue 7169, 2007, Pages 566-569

  Collison, Lauren W ^a   Workman, Creg J ^a   Kuo, Timothy T ^b   Boyd, Kelli ^a   Wang, Yao ^a   Vignali, Kate M ^a   Cross, Richard ^a   Sehy, David ^c   Blumberg, Richard S ^b   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c eBioscience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 27; INTERLEUKIN 27BETA; INTERLEUKIN 35; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ASTHMA; DIGESTIVE SYSTEM DISORDER; GENE EXPRESSION; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNE SYSTEM; INHIBITOR; PHENOTYPE; VACCINATION; VIRUS;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENTERITIS; EPSTEIN BARR INDUCED VIRUS GENE 3; GENE EXPRESSION; GENETIC ANALYSIS; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS GENE;

ERAGROSTIS TEF; HUMAN HERPESVIRUS 4;

EID: 36549030784     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06306     Document Type: Article

References (44)

1. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32 (2001).
2. + regulatory T cells. Immunol. Rev. 212, 60-73 (2006).
3. Xystrakis, E., Boswell, S. E. & Hawrylowicz, C. M. T regulatory cells and the control of allergic disease. Expert Opin. Biol. Ther. 6, 121-133 (2006).
4. Coombes, J. L., Robinson, N. J., Maloy, K. J., Uhlig, H. H. & Powrie, F. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204, 184-194 (2005).
5. Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O. & Bandeira, A. On the ontogeny and physiology of regulatory T cells. Immunol. Rev. 182, 5-17 (2001).
6. Belkaid, Y., Blank, R. B. & Suffia, I. Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol. Rev. 212, 287-300 (2006).
7. Rouse, B. T., Sarangi, P. P. & Suvas, S. Regulatory T cells in virus infections. Immunol. Rev. 212, 272-286 (2006).
8. Kretschmer, K., Apostolou, I., Jaeckel, E., Khazaie, K. & von Boehmer, H. Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer. Immunol. Rev. 212, 163-169 (2006).
9. Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775 (2007).
10. Devergne, O. et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70, 1143-1153 (1996).
11. + T cells. Immunity 16, 779-790 (2002).
12. Nieuwenhuis, E. E. et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl Acad. Sci. USA 99, 16951-16956 (2002).
13. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
14. Devergne, O., Birkenbach, M. & Kieff, E. Epstein-Barrvirus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl Acad. Sci. USA 94, 12041-12046 (1997).
15. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
16. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
17. Mattner, F. et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26, 1553-1559 (1996).
18. Zahn, S. et al. Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major. Eur. J. Immunol. 35, 1106-1112 (2005).
19. Kullberg, M. C. et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203, 2485-2494 (2006).
20. Gran, B. et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169, 7104-7110 (2002).
21. Murphy, C. A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
22. Workman, C. J. & Vignali, D. A. A. Negative regulation of T cell homeostasis by LAG-3 (CD223). J. Immunol. 174, 688-695 (2004).
23. Izcue, A., Coombes, J. L. & Powrie, F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271 (2006).
24. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
25. Brombacher, F., Kastelein, R. A. & Alber, G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24, 207-212 (2003).
26. Fuss, I. J. et al. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12, 9-15 (2006).
27. Schrader, J. W. Interleukin is as interleukin does. Trends Immunol. 23, 573-574 (2002).
28. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
29. Huang, C. T. et al. Role of LAG-3 in regulatory T cells. Immunity 21, 503-513 (2004).
30. Kaplan, D. Autocrine secretion and the physiological concentration of cytokines. Immunol. Today 17, 303-304 (1996).
31. + T cells. Proc. Natl Acad. Sci. USA 98, 8738-8743 (2001).
32. Vignali, D. A. & Vignali, K. M. Profound enhancementof T cell activation mediated by the interaction between the T cell receptor and the D3 domain of CD4. J. Immunol. 162, 1431-1439 (1999).
33. Li, N., Workman, C. J., Martin, S. M. & Vignali, D. A. A. Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223). J. Immunol. 173, 6806-6812 (2004).
34. Li, N. et al. Metalloproteases regulate T cell proliferation and effector function via LAG-3. EMBO J 26, 494-504 (2007).
35. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
36. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
37. Szymczak-Workman, A. L., Vignali, K. M. & Vignali, D. A. A. in Gene Transfer: Delivery and Expression (eds Friedmann, T. & Rossi, J.) 137-147 (Cold Spring Harbor Laboratory, Cold Spring Harbor, 2006).
38. Szymczak, A. et al. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nature Biotechnol. 22, 589-594 (2004).
39. Szymczak, A. & Vignali, D. A. A. Development of 2A peptide-based strategies in the design of multicistronic vectors. Exp. Opin. Biol. Ther. 5, 627-638 (2005).
40. Holst, J., Vignali, K. M., Burton, A. R. & Vignali, D. A. A. Rapid analysis of T cell selection and function in vivo using T cell receptor retrogenic mice. Nature Methods 3, 191-197 (2006).
41. Hisada, M. et al. Potent antitumour activity of interleukin-27. Cancer Res. 64, 1152-1156 (2004).
42. Holst, J. et al. Generation of T cell receptor retrogenic mice. Nature Protocols 1, 406-417 (2006).
43. Persons, D. A. et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine haematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90, 1777-1786 (1997).
44. Persons, D. A., Mehaffey, M. G., Kaleko, M., Nienhuis, A. W. & Vanin, E. F. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 24, 167-182 (1998).